Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Falling Comet
1345.2000 -16.60 (-1.22%)
NSE Jun 19, 2025 12:03 PM
Volume: 26,216
 

1345.20
-1.22%
Sharekhan
Ipca Laboratories Limited’s (Ipca) earnings came above our estimates, as sales grew 32.9% y-o-y to Rs. 2,092 crore. Sales growth was led by 11.6% y-o-y growth in domestic branded formulations.
Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended